Skip to content

Can the Femoral Nerve Block be Improved by Ultrasound Guidance?

Can the Use of Ultrasound to Guide the Insertion of a Needle for an Anterior Psoas Compartment Nerve Block Increase Its Efficacy in Comparison to Traditional Techniques Utilising Loss of Resistance and Nerve Stimulation?

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00696150
Enrollment
269
Registered
2008-06-12
Start date
2008-07-31
Completion date
2010-08-31
Last updated
2008-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

ultrasound, hip, pain

Brief summary

Studies have suggested a link with effective pain relief and reduced illness and death in very unwell patients. This study will determine the most effective method of injecting local anaesthetic around the nerves which supply the hip joint. Local anaesthetic will be injected around the hips nerve supply using either ultrasound, loss of resistance or electrical nerve stimulator to guide the positioning of the needle on patients due for elective total hip replacement. The patient will then be observed for 30 minutes and the patient ability to move or feel the upper leg will recorded. A standard anaesthetic and a hip replacement operation will then be performed. Standard pain relief protocols will be used the operation and after the operation. After the operation we will record the amount of morphine used and how happy the patients have been with their treatment at 6 hours after the operation and at 24 hours after the operation. The first day the patient is able to walk on their new hip replacement will also be recorded.

Interventions

PROCEDUREdetermination of method with highest efficacy (ultrasound or nerve stimulator)

Use of ultrasound to guide the insertion of anterior psoas compartment block

The use of the nerve stimulator to guide insertion of the anterior psoas compartment block

PROCEDUREloss of resistance

Use of ultrasound to guide the insertion of anterior psoas compartment block

Sponsors

Golden Jubilee National Hospital
CollaboratorOTHER_GOV
NHS Greater Glasgow and Clyde
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Elective primary total hip arthroplasty under general anaesthesia * ASA\<=4 * Able to give informed consent * Able to cooperate with sensory and motor testing of lower limb function

Exclusion criteria

* Abnormal clotting screen (coagulopathy) or thrombocytopenia (\<100,000) * Acute mental test score of \<=7 at any time pre or post operatively * Allergy to local anaesthetic * Signs, symptoms or laboratory evidence of local infection or systemic sepsis * No pre-existing neurological deficit (sensory or motor) affecting lower limb * Patients with lower limb amputations

Design outcomes

Primary

MeasureTime frame
percentage of patients with effective regional analgesiaInduction of anaesthesia

Secondary

MeasureTime frame
sensory function in lateral cutaneous nerve0mins, 10mins 20mins post insertion of local anaesthetic
sensory function of femoral nerve0mins, 10mins, 20mins after insertion of local anesthetic
sensory function of obturator nerve0mins, 10mins, 20mins after insertion of local anesthetic
motor function of obturator nerve0mins, 10mins and 20minutes after insrtion of local anesthetic
hospital mortality1months after operation
acute mental test scores6hours and 24 hours post operatively
total morphine dose administered6hours and 24 hours post operstively
day first mobilise post operativelypost operatively 0-10 days
patient satisfaction scores6 hours and 24hours post operatively
motor function of femoral nerve0mins,10mins and 20mins post insertion of local anesthetic

Countries

United Kingdom

Contacts

Primary ContactMalcolm Watson, MBChB, MRCP, FRCA
mwatson@doctors.org.uk01412116291

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026